RNF40
Basic information
Region (hg38): 16:30761745-30776307
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RNF40 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 44 | 45 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 44 | 3 | 2 |
Variants in RNF40
This is a list of pathogenic ClinVar variants found in the RNF40 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-30762620-G-C | not specified | Uncertain significance (Jun 21, 2023) | ||
16-30763143-A-G | not specified | Uncertain significance (Mar 08, 2024) | ||
16-30763169-C-T | not specified | Uncertain significance (Mar 19, 2024) | ||
16-30763203-T-A | not specified | Uncertain significance (Sep 27, 2022) | ||
16-30763222-G-A | not specified | Likely benign (Mar 07, 2024) | ||
16-30763497-C-T | not specified | Uncertain significance (Oct 27, 2022) | ||
16-30763508-C-T | not specified | Uncertain significance (Oct 06, 2021) | ||
16-30764192-G-C | not specified | Uncertain significance (Apr 25, 2023) | ||
16-30764349-C-T | not specified | Uncertain significance (Jun 16, 2023) | ||
16-30764350-G-A | not specified | Likely benign (Nov 22, 2022) | ||
16-30764371-G-A | not specified | Uncertain significance (Jun 30, 2022) | ||
16-30764383-G-A | not specified | Uncertain significance (Jul 14, 2021) | ||
16-30764383-G-C | not specified | Uncertain significance (Mar 12, 2024) | ||
16-30764980-G-A | not specified | Uncertain significance (Jan 04, 2022) | ||
16-30765022-C-T | not specified | Uncertain significance (Feb 06, 2023) | ||
16-30766215-G-A | not specified | Uncertain significance (Oct 26, 2021) | ||
16-30766270-T-A | not specified | Uncertain significance (Mar 23, 2022) | ||
16-30766274-C-T | not specified | Uncertain significance (Sep 17, 2021) | ||
16-30766394-C-A | not specified | Uncertain significance (Apr 08, 2024) | ||
16-30766428-A-G | not specified | Uncertain significance (Jan 10, 2022) | ||
16-30766449-T-A | not specified | Uncertain significance (Nov 30, 2021) | ||
16-30766518-C-T | not specified | Uncertain significance (Sep 07, 2022) | ||
16-30766546-C-T | Likely benign (Mar 29, 2018) | |||
16-30766813-C-T | not specified | Uncertain significance (Nov 15, 2021) | ||
16-30766814-G-T | not specified | Uncertain significance (Nov 14, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RNF40 | protein_coding | protein_coding | ENST00000324685 | 19 | 14563 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000129 | 125651 | 0 | 97 | 125748 | 0.000386 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.70 | 439 | 630 | 0.697 | 0.0000422 | 6435 |
Missense in Polyphen | 62 | 156.21 | 0.3969 | 1712 | ||
Synonymous | 1.18 | 223 | 247 | 0.904 | 0.0000144 | 2032 |
Loss of Function | 6.27 | 8 | 60.8 | 0.132 | 0.00000395 | 608 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000308 | 0.000304 |
Ashkenazi Jewish | 0.0000995 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000781 | 0.000756 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000328 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the RNF20/40 E3 ubiquitin-protein ligase complex that mediates monoubiquitination of 'Lys-120' of histone H2B (H2BK120ub1). H2BK120ub1 gives a specific tag for epigenetic transcriptional activation and is also prerequisite for histone H3 'Lys-4' and 'Lys-79' methylation (H3K4me and H3K79me, respectively). It thereby plays a central role in histone code and gene regulation. The RNF20/40 complex forms a H2B ubiquitin ligase complex in cooperation with the E2 enzyme UBE2A or UBE2B; reports about the cooperation with UBE2E1/UBCH are contradictory. Required for transcriptional activation of Hox genes. {ECO:0000269|PubMed:16307923, ECO:0000269|PubMed:19410543}.;
- Pathway
- ATM Signaling Network in Development and Disease;Post-translational protein modification;Metabolism of proteins;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins
(Consensus)
Recessive Scores
- pRec
- 0.176
Intolerance Scores
- loftool
- 0.457
- rvis_EVS
- -1.99
- rvis_percentile_EVS
- 1.76
Haploinsufficiency Scores
- pHI
- 0.320
- hipred
- Y
- hipred_score
- 0.785
- ghis
- 0.634
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.674
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rnf40
- Phenotype
Gene ontology
- Biological process
- ubiquitin-dependent protein catabolic process;regulation of mitotic cell cycle;histone monoubiquitination;protein ubiquitination;histone H2B ubiquitination;response to peptide hormone;negative regulation of mRNA polyadenylation;positive regulation of proteasomal protein catabolic process;positive regulation of protein polyubiquitination;positive regulation of histone H2B ubiquitination
- Cellular component
- ubiquitin ligase complex;nucleus;nucleoplasm;cytosol;membrane;extrinsic component of membrane;HULC complex;neuron projection;axon terminus
- Molecular function
- mRNA 3'-UTR binding;ubiquitin-protein transferase activity;protein binding;syntaxin-1 binding;ubiquitin conjugating enzyme binding;ubiquitin protein ligase binding;protein homodimerization activity;protein-containing complex binding;metal ion binding